Skip to main content
Clinical Trials/NCT05783310
NCT05783310
Completed
N/A

Effectiveness of Psychoeducation Intervention on Reducing Negative Psychological Outcomes and Enhancing Coping of Caregivers of Children With Cancer: A Randomized Controlled Trial

Chinese University of Hong Kong2 sites in 1 country118 target enrollmentMay 22, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Pediatric Cancer
Sponsor
Chinese University of Hong Kong
Enrollment
118
Locations
2
Primary Endpoint
Anxiety level
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This randomized controlled trial aims to evaluate the effectiveness of the psychoeducation intervention on anxiety, depressive symptoms, coping, and HRQoL in caregivers of children with cancer.

The study is a two-arm parallel-group single-blind, randomized controlled trial that will be conducted in two hospitals in Malawi.

Detailed Description

Aim of the study To develop and implement psychoeducation intervention that meet the need of caregivers of children with cancer in Malawi. Objectives of the study 1. To develop a psychoeducation intervention that addresses the needs of caregivers of children with cancer in Malawian culture. 2. To evaluate the effectiveness of the PEI in reducing anxiety and depressive symptoms and enhancing coping and HRQoL among caregivers of children with cancer in Malawi. Hypotheses of the study 1. Compared with the control group, caregivers in the intervention group will have significantly lower anxiety levels immediately after the intervention, and at 3 months post-intervention. 2. Compared with the control group, caregivers in the intervention group will have significantly fewer depressive symptoms immediately after the intervention, and at 3 months post-intervention. 3. Compared with the control group, caregivers in the intervention group will have significantly better HRQoL, immediately after the intervention, and at 3 months post-intervention. 4. Compared with the control group, caregivers in the intervention group will have significantly better coping skills immediately after the intervention, and at 3 months post-intervention.

Registry
clinicaltrials.gov
Start Date
May 22, 2023
End Date
December 30, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Lophina Phiri

Principal Investigator

Chinese University of Hong Kong

Eligibility Criteria

Inclusion Criteria

  • Caregivers will be included if the child is within the one-year post-cancer diagnosis and on treatment, the primary carer of the child, the child is aged ≤ 15 years, caregivers are above 18 years, and caregivers must have a score of more than five on GAD-7 score. A score of 5 is the cut-off point for anxiety in this questionnaire.

Exclusion Criteria

  • Caregivers of children with other co-morbidities will be excluded from the study.

Outcomes

Primary Outcomes

Anxiety level

Time Frame: Three months post-intervention

Anxiety will be measured using the General Anxiety Disorder questionnaire (GAD-7) GAD-7 is a 7-item scale that assesses anxiety symptoms on a 4-point scale (0=not at all to 3=nearly every day). The final score is determined by summing the scores for the seven items. Scores 5, 10, and 15 represent the cut-off points for mild, moderate, and severe anxiety, respectively.

Secondary Outcomes

  • Coping(Baseline, immediately after intervention and three months follow up)
  • Depressive symptoms(Baseline, immediately after intervention and three months follow up)
  • Health-related quality of life(Baseline, immediately after intervention and three months follow up)

Study Sites (2)

Loading locations...

Similar Trials